The Surveillance of Vancomycin- Resistant Enterococci Colonization by (Cepheid) GeneXpert vanA/vanB Test and Culture Method

Yıl 2014, , 97 - 101, 01.09.2014

Hatice Uludağ Altun Çiğdem Ataman Hatipoğlu Cemal Bulut Server Yağcı , Günay Tuncer Ertem Sami Kınıklı Ali Pekcan Demiröz

https://doi.org/10.5799/ahinjs.02.2014.03.0147

Öz

Objectives: Early detection of vancomycin resistant enterococci (VRE) colonization in hospitalized patients plays an important role in controlling enterococcal infections. For this purpose, the detection of VRE from rectal swab specimens can be performed with various methods. Methods: In this study, VRE colonization in the rectal swab samples of patients from intensive care units, burn unit, and infectious diseases clinic in our hospital were evaluated. In total, 2,394 rectal swab samples from 1,627 patients were collected between January 2012 and 2013. A commercial product (Enterococcosel agar) was used for cultivating, and the growing bacteria were identified with conventional methods and/or the VITEK 2 Compact system (BioMerieux, France). The samples of the patients transferred from another hospital and who had a history of VRE infection or carriage were examined with an automated real-time PCR system (Gene Xpert™ vanA/vanB, Cepheid, Sunnyvale, CA). Results: A total of 59 (3.6%) patients were positive for VRE, 25 were diagnosed with PCR, and 34 were diagnosed with culture methods. Among the samples identified by PCR, 19 were only vanA harboring VRE, five were only vanB harboring VRE, and one was both vanA and vanB harboring VRE. All of the VRE isolates were identified as E. faecium. The number of patients admitted with vancomycin therapy before being diagnosed with VRE was 11(18.6%). Conclusions: It is important to determine the appropriate surveillance method for the early diagnosis of VRE carriers among patients at risk according to their patient profile, needs, and resources.

Anahtar Kelimeler

Vancomycin-resistant enterococci, vanA, vanB, Gene Xpert™

The Surveillance of Vancomycin- Resistant Enterococci Colonization by (Cepheid) GeneXpert vanA/vanB Test and Culture Method

Öz

Amaç: Hastanede yatan hastalarda vankomisin dirençli enterokok (VRE) kolonizasyonunun erken tespiti, enterokok enfeksiyonlarının kontrolünde önemli bir yer tutmaktadır. Bu amaçla rektal sürüntü örneklerinde çeşitli yöntemlerle VRE tespiti yapılabilmektedir.Yöntemler: Bu çalışmada hastanemizde Ocak 2012-2013 tarihleri arasında, yoğun bakım ünitelerinde, yanık ve enfeksiyon hastalıkları kliniklerinde yatmakta olan 1627 hastaya ait 2394 rektal sürüntü örneğinde VRE kolonizasyonu araştırıldı. Bu amaçla kültür için Enterokokosel agar kullanıldı. Üreyen bakteriler konvansiyonel yöntemler ve/veya VITEK 2 Compact (BioMerieux, Fransa) ticari sistemi kullanılarak tür düzeyinde tanımlandı. Başka bir hastaneden nakil gelen ve daha önce VRE enfeksiyonu veya taşıyıcılığı öyküsü olanlarda rektal örnekler otomatize gerçek zamanlı polimeraz zincir reaksiyonu (Realtime PCR) cihazı (Gene Xpert™ vanA/vanB, Cepheid, Sunnyvale, CA) ile incelendi.Bulgular: Toplam 59 hastada VRE pozitifliği (%3,6) saptandı. Bunların 25’i PCR, 34’ü ise kültür ile çalışıldı. PCR ile tanı konulanlardan 19’u vanA pozitif, 5’i vanB pozitif, biri ise vanA+vanB pozitif olarak saptandı. Vankomisin dirençli enterokok olarak belirlenen tüm suşlar E. faecium olarak tanımlandı. Hastalardan 11(%18.6)’nın VRE tanısı öncesinde tedavisinde vankomisin kullandığı saptandı.Sonuç: Riskli hastalarda VRE taşıyıcılığını erken dönemde saptayabilmek için her hastanenin kendi hasta profiline, ihtiyaçlarına ve kaynaklarına göre uygun sürveyans yöntemini belirlemesi gerektiğini düşünmekteyiz

Anahtar Kelimeler

Vankomisine dirençli enterokok, vanA, vanB, Gene Xpert™

Kaynakça

• Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-Resistant En- terococci. Clin Microbiol Rev 2000;13:686-707.
• D’Agata EM, Horn MA, Webb GF. The impact of persis- tent gastrointestinal colonization on the transmission dy- namics of vancomycin-resistant enterococci. J Infect Dis 2002;185:766-773.
• Sloan LM, Uhl JR, Vetter EA, et al. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for de- tection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol 2004;42:2636-2643.
• Clinical and Laboratory Standards Institute. M100-S23. Per- formance standards for antimicrobial susceptibility test- ing. 23th Informational Supplement M02-M07, 2013. CLSI, Wayne, PA.
• http://hastaneenfeksiyonları.saglık.gov.tr/dosya/VRE.pdf.
• Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analy- sis and genotypic characterization of a nosocomial out- break of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-1285.
• Peset V, Tallón P, Sola C, et al. Epidemiological, microbiologi- cal, clinical and prognostic factors of bacteremia caused by high-level vancomycin-resistant enterococcus species. Eur J Clin Microb Infect Dis 2000;19:742-749.
• Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predic- tors of mortality in patients colonised with vancomycin-resis- tant enterococci. Clin Microbiol Infect 2008;14:14-21.
• Tornieporth NG, Roberts RB, John J, et al. Risk factors associ- ated with vancomycin-resistant Enterococcus faecium infec- tion or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-772.
• Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin resistant enterococcus among pa- tients with cancer. Am J Infect Control 2006;34:534-536.
• Harris AD, Nemoy L, Johnson JA, et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of inten- sive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004;25:105-108.
• Endtz HP, Braak N, Belkum A, et al. Fecal carriage of van- comycin-resistant enterococci in hospitalized patients and those living in the community in the Netherlands. J Clin Mi- crobiol 1997;35:3026-3031.
• Gordts B, Van Landuyt H, Ieven M, et al. Vancomycin-resis- tant enterococci colonizing the intestinal tracts of hospital- ized patients. J Clin Microbiol 1995;33:2842-2846.
• Ergani-Ozcan A, Naas T, Baysan BO, et al. Nosocomial out- break of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. J Antimicrob Chemother 2008;61:1033-1039.
• Aygün H, Memikoğlu O, Tekeli A, et al. Surveillance for vancomycin resistant enterococci colonization among high risk hospitalized patients. Türk Anest Rean Der Derg 2008;36:168-173.
• Uttley AH, Collins CH, Naidoo J, George RS. Vancomycin- resistant enterococci. Lancet 1988;1:57-58.
• Woodford N. Glycopeptide-resistant enterococci: a decade of experience. J Med Microbiol 1998;47:849-862.
• Colak D, Naas T, Gunseren F, et al. First outbreak of vanco- mycin-resistant enterococci in a tertiary hospital in Turkey. J Antimicrob Chemother 2002;50:397-401.
• Kilic A, Baysallar M, Bahar G, et al. Evaluation of the EVI- GENE VRE detection kit for detection of vanA and vanB genes in vancomycin-resistant enterococci. J Med Microbiol 2005;54:347-350.
• Atalay S, Ece G, Samlıoğlu P, et al. Evaluation of vancomy- cin-resistant enterococcus cases at a tertiary level hospital in Izmir, Turkey. Mikrobiyol Bul 2012;46:553-559.
• Coşkun FA, Mumcuoğlu I, Aksu N. Phenotypic and genotypic traits of vancomycin-resistant enterococci in a public hospi- tal: The first vanB-positive Enterococcus faecium ısolates. Mikrobiyol Bul 2012;46:276-282.
• Domingo MC, Huletsky A, Giroux R, et al. High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother 2005;49:4784–4786.
• Graham M, Ballard SA, Grabsch EA, et al. High rates of fe- cal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother 2008;52:1195-1197.
• Mak A, Miller MA, Chong G, Monczak Y. Comparison of PCR and culture for screening of vancomycin-resistant enterococ- ci: highly disparate results for vanA and vanB. J Clin Micro- biol 2009;47:4136-4137.
• Stinear TP, Olden DC, Johnson PD, et al. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lan- cet 2001;357:855-856.
• Marvaud JC, Mory F, Lambert T. Clostridium clostridioforme and Atopobium minutum clinical isolates with vanB-type re- sistance in France. J Clin Microbiol 2011;49:3436-3438.
• Dutka-Malen S, Evers S, Courvalin P. Detection of glycopep- tide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Micro- biol 1995;33:24-27.
• Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-1015.
• Gazin M, Lammens C, Goossens H, et al. Evaluation of Ge- neOhm vanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci. Eur J Clin Microbiol Infect Dis 2011; 31:273-276.
• Marner ES, Wolk DM, Carr J, et al. Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Entero- coccus from perianal specimens. Diagn Microbiol Infect Dis 2011;69:382-389.